Effect of Epicutaneous Immunotherapy on Inducing Peanut Desensitization in Peanut-Allergic Children: Topline Peanut Epicutaneous Immunotherapy Efficacy and Safety (PEPITES) Randomized Clinical Trial Results
Year: 2018
Type: article
Study design: Clinical Trial
Authors: David M. Fleischer, Gordon Lloyd Sussman, Philippe Begin, Anna H. Nowak-Wegrzyn, Kirsten Beyer, Stephen A. Tilles, Terri F. Brown-Whitehorn, Jacques Hébert, Jonathan O'B. Hourihane, Dianne Campbell, Stephanie A. Leonard, Sharon Chinthrajah, Jacqueline A. Pongracic, Stacie M. Jones, Lars Lange, Todd David Green, Robert A. Wood, Wayne G. Shreffler
Institutions: Children's Hospital Colorado, University of Colorado Anschutz, University of Toronto, Centre Hospitalier Universitaire Sainte-Justine, Icahn School of Medicine at Mount Sinai, Charité - Universitätsmedizin Berlin, Children's Hospital of Philadelphia, University College Cork, Children's Hospital at Westmead, University of California San Diego, Rady Children's Hospital-San Diego, Lucile Packard Children's Hospital, Stanford University, Lurie Children's Hospital, Arkansas Children's Hospital, St. Marien-Hospital Bonn, Children's Hospital of Pittsburgh, Johns Hopkins University, Massachusetts General Hospital
Language: English
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2784746066